Medirom Healthcare Valuation
| MRM Stock | USD 1.41 0.02 1.44% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Medirom Healthcare secures a last-minute Real Value of $1.11 per share. The latest price of the firm is $1.41. Our model forecasts the value of Medirom Healthcare from analyzing the firm fundamentals such as Profit Margin of 0.02 %, current valuation of 35.52 M, and Return On Equity of 0.23 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Medirom Healthcare's price fluctuation is out of control at this time. Calculation of the real value of Medirom Healthcare is based on 3 months time horizon. Increasing Medirom Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medirom stock is determined by what a typical buyer is willing to pay for full or partial control of Medirom Healthcare Technologies. Since Medirom Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medirom Stock. However, Medirom Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.41 | Real 1.11 | Hype 1.41 | Naive 1.52 |
The intrinsic value of Medirom Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medirom Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medirom Healthcare Technologies helps investors to forecast how Medirom stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medirom Healthcare more accurately as focusing exclusively on Medirom Healthcare's fundamentals will not take into account other important factors: Medirom Healthcare Total Value Analysis
Medirom Healthcare Technologies is now projected to have company total value of 35.52 M with market capitalization of 11.17 M, debt of 3.96 B, and cash on hands of 354.95 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Medirom Healthcare fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
35.52 M | 11.17 M | 3.96 B | 354.95 M |
Medirom Healthcare Investor Information
About 26.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.78. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medirom Healthcare had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Medirom Healthcare's historical financial statements, Medirom Healthcare Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Medirom Healthcare Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Medirom suggests not a very effective usage of assets in July.Medirom Healthcare Ownership Allocation
The market capitalization of Medirom Healthcare Technologies is $11.17 Million. Medirom Healthcare Technologies holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Medirom Healthcare Profitability Analysis
The company reported the last year's revenue of 8.3 B. Total Income to common stockholders was 138.19 M with profit before taxes, overhead, and interest of 2.25 B.About Medirom Healthcare Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Medirom Healthcare Technologies. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Medirom Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing Medirom Healthcare's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Medirom Healthcare's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medirom Healthcare. We calculate exposure to Medirom Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medirom Healthcare's related companies.MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan. MEDIROM Healthcare operates under Personal Services classification in the United States and is traded on NASDAQ Exchange. It employs 171 people.
Medirom Healthcare Growth Indicators
Investing in growth stocks can be very risky. If the company such as Medirom Healthcare does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 5.9 M | |
| Quarterly Earnings Growth Y O Y | 0.278 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.